8-K: Aeluma Director Halts 130,000 Share Sale Plan

Aeluma, Inc. announced that Director Steven DenBaars terminated his Rule 10b5-1 trading plan, preventing the sale of up to 130,000 shares.

Summary

• Aeluma, Inc. Director Steven DenBaars terminated a Rule 10b5-1 trading arrangement on September 16, 2025.
• The plan, adopted on June 23, 2025, was for the sale of up to 130,000 shares of the company's common stock.
• The original sale window for these shares was scheduled between October 6, 2025, and May 6, 2026.
• Due to the termination, no sales were or will be made pursuant to this specific 10b5-1 Plan.

Sentiment

Score: 6

Explanation: The termination of a director's plan to sell a significant number of shares removes a potential source of selling pressure, which is generally viewed as a slight positive for the stock.

Positives

• The termination of the 10b5-1 plan means that up to 130,000 shares of common stock will not be sold by the director as previously planned, removing potential selling pressure from the market.

Future Outlook

No sales will be made pursuant to the terminated Rule 10b5-1 Plan.

Industry Context

Rule 10b5-1 trading plans are common mechanisms for company insiders to sell shares in a pre-arranged, compliant manner. The termination of such a plan, especially for a significant number of shares, can be interpreted by the market as a change in the insider's liquidity needs or outlook on the company's stock, potentially reducing perceived future selling pressure.

Stakeholder Impact

• Shareholders may perceive the termination of the selling plan as a positive signal, as it removes the potential for 130,000 shares to enter the market from this specific insider, potentially reducing downward price pressure.

Key Dates

Keywords

Aeluma, ALMU, 10b5-1 plan, insider trading, director, stock sale, trading arrangement